IMA
ImageneBio, Inc.Company Information
- Company Name
- ImageneBio, Inc.
- CIK
- CIK0001835579
- Category
- Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
- Ticker: Exchange
- IMA: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2836
- SIC Description
- Biological Products, (No Diagnostic Substances)
- Ticker
- IMA
SEC filing data through
Insider Sentiment
- Last purchase
- 2025-12-24
- Last sale
- 2026-07-17
- Shares purchased (TTM)
- 367,167
- Shares sold (TTM)
- 1,525
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 6,330,835
- Shares outstanding
- 16,161,721
- Ownership
- 39.17%
Earnings Market Reaction
- Filing date
- 2026-08-05
- Price on filing date
- —
- 1-month reaction
- -7.13%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Series A Convertible Preferred Stock | - | - | - | - | - | - | 19 | - | - | - | - | - | ||||||
| Related Party | -3 | 6 | 7 | 8 | - | - | 0 | - | - | - | - | - | ||||||
| Voting Common Stock | 0 | 0 | 0 | 0 | - | - | 0 | - | - | - | - | - | ||||||
| Nonvoting Common Stock | 0 | 0 | - | - | - | - | - | - | - | - | - | - | ||||||
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 95 | 76 | 95 | 103 | 58 | 37 | 12 | 45 | 44 | 53 | 120 | 121 | ||||||
| Property Plant And Equipment Net | - | - | 0 | - | 0 | 1 | 0 | 1 | 1 | 1 | 2 | 3 | ||||||
| Marketable Securities Current | 41 | 41 | 41 | 39 | 37 | 77 | 0 | 93 | 101 | 104 | 56 | 76 | ||||||
| Prepaid Expense And Other Assets Current | 5 | 5 | 5 | 5 | 3 | 3 | 0 | 4 | 4 | 4 | 3 | 4 | ||||||
| Temporary Equity Par Or Stated Value Per Share | - | - | 0.00 | 0.00 | - | - | 0.00 | - | - | - | - | - | ||||||
| Temporary Equity Shares Authorized | - | - | 0 | 0 | - | - | 3 | - | - | - | - | - | ||||||
| Temporary Equity Shares Issued | - | - | 0 | 0 | - | - | 2 | - | - | - | - | - | ||||||
| Temporary Equity Shares Outstanding | - | - | 0 | 0 | - | - | 2 | - | - | - | - | - | ||||||
| Temporary Equity Liquidation Preference | - | - | 0 | 0 | - | - | 164 | - | - | - | - | - | ||||||
| Assets Current | 141 | 122 | 140 | 148 | 99 | 117 | 12 | 142 | 149 | 161 | 179 | 201 | ||||||
| Operating Lease Right Of Use Asset | 1 | 1 | 1 | 1 | 3 | 3 | 1 | 4 | 5 | 5 | 6 | 8 | ||||||
| Other Assets Noncurrent | - | - | 5 | 5 | - | - | 1 | - | - | - | - | - | ||||||
Assets Noncurrent | ||||||||||||||||||
| Assets | 152 | 137 | 153 | 161 | 126 | 131 | 16 | 149 | 157 | 173 | 192 | 215 | ||||||
Liabilities Current | ||||||||||||||||||
| Other Long Term Debt Noncurrent | - | - | - | - | - | - | 1 | - | - | - | 1 | 1 | ||||||
| Accounts Payable Current | 1 | 1 | 1 | 2 | 1 | 1 | 5 | 2 | 1 | 2 | 2 | 4 | ||||||
| Accrued Liabilities And Other Liabilities | 4 | 4 | 8 | 7 | 3 | 4 | 3 | 4 | 3 | 5 | 9 | - | ||||||
| Deferred Revenue Current | - | - | 0 | 0 | - | - | 1 | - | - | - | - | - | ||||||
| Operating Lease Liability Current | 2 | 2 | 2 | 2 | 4 | 4 | 0 | 4 | 4 | 3 | 4 | 3 | ||||||
| Contract With Customer Liability Current | - | - | - | - | - | - | - | - | - | - | - | 1 | ||||||
| Debt Current | - | - | 0 | 0 | - | - | 8 | - | - | - | - | - | ||||||
| Liabilities Current | 7 | 7 | 11 | 11 | 7 | 9 | 17 | 9 | 8 | 10 | 14 | 19 | ||||||
| Operating Lease Liability Noncurrent | 0 | 0 | 1 | 1 | 2 | 3 | 0 | 4 | 5 | 6 | 7 | 8 | ||||||
| Other Liabilities Noncurrent | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | - | - | ||||||
| Liabilities | 10 | 13 | 20 | 21 | 10 | 13 | 17 | 15 | 15 | 17 | 22 | 28 | ||||||
| Common Stock Value | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Liabilities Noncurrent | ||||||||||||||||||
| Preferred Stock Value | 0 | 0 | - | - | - | - | - | - | - | - | - | - | ||||||
| Additional Paid In Capital | 393 | 364 | 363 | 363 | 459 | 458 | 2 | 456 | 455 | 454 | 452 | 418 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -0 | -0 | 0 | 0 | 0 | 0 | -2 | 0 | -0 | -0 | -0 | -0 | ||||||
| Retained Earnings Accumulated Deficit | -251 | -241 | -230 | -223 | -343 | -340 | -180 | -322 | -312 | -299 | -282 | -263 | ||||||
Temporary Equity | ||||||||||||||||||
| Redeemable Noncontrolling Interest Equity Preferred Carrying Amount | - | - | - | - | - | - | 159 | - | - | - | - | - | ||||||
| Redeemable Noncontrolling Interest Equity Carrying Amount | - | - | - | - | - | - | 159 | - | - | - | - | - | ||||||
| Stockholders Equity | 142 | 123 | 133 | 140 | -180 | -170 | -161 | -153 | 143 | 155 | 170 | 155 | ||||||
| Liabilities And Stockholders Equity | 152 | 137 | 153 | 161 | 126 | 131 | 16 | 149 | 157 | 173 | 192 | 215 | ||||||
| Series A Non Voting Convertible Preferred Stock | - | - | - | - | - | - | - | - | - | - | - | 0 | ||||||
| Series A Convertible Preferred Shares | - | - | 0 | 0 | - | - | 0 | - | - | - | - | - | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 10 | 10 | 10 | 10 | 10 | 10 | 0 | 10 | 10 | 10 | 10 | 10 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | - | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | - | - | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | ||||||
| Common Stock Shares Issued | - | - | - | - | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | ||||||
| Shares Outstanding | - | - | - | - | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialImageneBio, Inc. (IMA) — SEC Financial Statements & Analysis
ImageneBio, Inc. (IMA) is a biological products, (no diagnostic substances) company, incorporated in DE. ImageneBio, Inc. trades on Nasdaq as: IMA. ImageneBio, Inc. (IMA)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-05. Based on that filing, ImageneBio, Inc. carries a market cap of $95.35M, a P/E ratio of -1.69x, a P/B ratio of 0.67x, a P/S ratio of 119.19x, an enterprise value of $677.16K, and an EV/EBITDA multiple of -0.01x. On profitability, it posts an operating margin of -7370.13%, a net margin of -7059.88%, a Return on Equity (ROE) of 295.11%, a Return on Assets (ROA) of -40.60%, and a Return on Invested Capital (ROIC) of -81.93%. Per share, it reports EPS of $-3.49, diluted EPS of $-3.49, free cash flow per share of $-3.25, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -81.40% year-over-year, net income growth of 141.31% year-over-year, and EPS growth of -98.20% year-over-year. On the balance sheet, it maintains a current ratio of 21.47x, a quick ratio of 20.71x, working capital of $134.54M, a debt-to-equity ratio of 0.07x, a debt ratio of 0.07, an interest coverage ratio of -11.99x, free cash flow of $-52.59M (TTM), and net debt of $-94.68M. Figures sourced from SEC EDGAR.
- Market Cap
- $95.35M
- P/E TTM
- -1.69x
- EPS TTM
- $-3.49
- P/B TTM
- 0.67x
- ROE TTM
- 295.11%
- ROA TTM
- -40.60%
- Debt To Equity
- 0.07x
- Free Cash Flow TTM
- $-52.59M
- Net Revenue TTM Growth 1Y
- -81.40%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is ImageneBio, Inc. in?
ImageneBio, Inc. (IMA) operates in the Biological Products, (No Diagnostic Substances) industry.
What exchange does IMA trade on?
ImageneBio, Inc. (IMA) trades on the Nasdaq.
Where is ImageneBio, Inc. incorporated?
ImageneBio, Inc. is incorporated in DE.
When was ImageneBio, Inc. (IMA)'s most recent SEC filing?
ImageneBio, Inc. (IMA)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-05.
What is IMA's market cap?
ImageneBio, Inc. (IMA) has a market capitalization of $95.35M as of 2026-06-30.
What is IMA's EPS (earnings per share)?
ImageneBio, Inc. (IMA)'s trailing twelve month EPS is $-3.49 as of 2026-06-30.
What is IMA's ROE (return on equity)?
ImageneBio, Inc. (IMA)'s trailing twelve month Return on Equity (ROE) is 295.11% as of 2026-06-30.
What is IMA's ROA (return on assets)?
ImageneBio, Inc. (IMA)'s trailing twelve month Return on Assets (ROA) is -40.60% as of 2026-06-30.
What is IMA's ROIC (return on invested capital)?
ImageneBio, Inc. (IMA)'s trailing twelve month Return on Invested Capital (ROIC) is -81.93% as of 2024-06-30.
What is IMA's EV/EBITDA?
ImageneBio, Inc. (IMA)'s trailing twelve month EV/EBITDA is -0.01x as of 2026-06-30.